HIGHLIGHTS
- who: Zi-mei Lin and collaborators from the University, China have published the Article: A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers, in the Journal: (JOURNAL)
- what: The authors aimed at to evaluate whether a predictive model based on a CEUS-based nomogram and clinical features (Clin) could differentiate Her-2-overexpressing breast cancers from OMs. Unfortunately, in the current study, the combination of clinical and CEUS features showed no significant diagnostic performance in predicting Her-2-overexpression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.